Camargo Pharmaceutical Services

With a generic cliff approaching, the 505(b)(2) development process can make changes to reference products for greater profit potential and lower risk. Camargo offers a clear process to identify products that have documented market differentiation. With global reach across 26 countries, Camargo executes 505(b)(2) programs for both small and large molecules. Download more….click here.

Looking to identify a new product for development? Ready to roll over a compound into a new application? The 505(b)(2) pathway is a fast and cost-effective route for drug approval. With global reach across 26 countries, Camargo Pharmaceutical Services executes 505(b)(2) programs for both small and large molecules.